MyMSTeam

Yes, there are other medications available for treating multiple sclerosis after Ocrevus (Ocrelizumab). Here are a few options:

- Ublituximab (Briumvi): This is the most recent FDA-approved infusion drug for treating relapsing forms of MS. It is infused once every 24 weeks
- Mitoxantrone (Novantrone): This was the first Show Full Answer

Yes, there are other medications available for treating multiple sclerosis after Ocrevus (Ocrelizumab). Here are a few options:

- Ublituximab (Briumvi): This is the most recent FDA-approved infusion drug for treating relapsing forms of MS. It is infused once every 24 weeks.
- Mitoxantrone (Novantrone): This was the first long-term drug to treat relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS), though it is now prescribed less often.

For more detailed information, you can visit the MyMSTeam website or consult with a healthcare provider.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Study of MS Drug Ocrevus Seeks Black and Hispanic Participants | MyMSTeam

Ocrevus (Ocrelizumab) for Multiple Sclerosis | MyMSTeam